These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10036999)

  • 1. The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis.
    Valk PJ; Delwel R
    Leuk Lymphoma; 1998 Dec; 32(1-2):29-43. PubMed ID: 10036999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.
    Valk P; Verbakel S; Vankan Y; Hol S; Mancham S; Ploemacher R; Mayen A; Löwenberg B; Delwel R
    Blood; 1997 Aug; 90(4):1448-57. PubMed ID: 9269762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic predisposition of pSca-1/Cb2 transgenic mice.
    Joosten M; Valk PJ; Jordà MA; Vankan-Berkhoudt Y; Verbakel S; van den Broek M; Beijen A; Löwenberg B; Delwel R
    Exp Hematol; 2002 Feb; 30(2):142-9. PubMed ID: 11823049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2.
    Jorda MA; Rayman N; Valk P; De Wee E; Delwel R
    Ann N Y Acad Sci; 2003 May; 996():10-6. PubMed ID: 12799277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.
    Valk PJ; Vankan Y; Joosten M; Jenkins NA; Copeland NG; Löwenberg B; Delwel R
    J Virol; 1999 May; 73(5):3595-602. PubMed ID: 10196250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
    Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11.
    Valk PJ; Hol S; Vankan Y; Ihle JN; Askew D; Jenkins NA; Gilbert DJ; Copeland NG; de Both NJ; Löwenberg B; Delwel R
    J Virol; 1997 Sep; 71(9):6796-804. PubMed ID: 9261404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation.
    Jordà MA; Lowenberg B; Delwel R
    Blood; 2003 Feb; 101(4):1336-43. PubMed ID: 12406867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
    McKallip RJ; Lombard C; Fisher M; Martin BR; Ryu S; Grant S; Nagarkatti PS; Nagarkatti M
    Blood; 2002 Jul; 100(2):627-34. PubMed ID: 12091357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol.
    Jordà MA; Verbakel SE; Valk PJ; Vankan-Berkhoudt YV; Maccarrone M; Finazzi-Agrò A; Löwenberg B; Delwel R
    Blood; 2002 Apr; 99(8):2786-93. PubMed ID: 11929767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of cannabinoid CB1 and CB2 receptors.
    Pertwee RG
    Pharmacol Ther; 1997; 74(2):129-80. PubMed ID: 9336020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.